Fig 6. Estimation of time-to-event curves via IP weighted hazards model (and 95% confidence intervals calculated via bootstrapping) for treatment escalation in dogs attending primary-care practices in the UK prescribed gastrointestinal nutraceuticals (G = 1) and dogs not prescribed gastrointestinal nutraceuticals (G = 0) at first presentation for acute diarrhoea.